PTGX
Protagonist Therapeutics, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang +20.0% ·
aliran saham -30.0% ·
posisi baru bersih +16.7%
— formula
Fragmentasi kepemilikan — lebih banyak pemegang, agregat kepemilikan lebih kecil
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 106 | +1 | 45.41M | $5.57B | +7 | −6 |
| Q1 2026 | 108 | -1 | 49.99M | $5.27B | +9 | −10 |
| Q4 2025 | 107 | +4 | 45.87M | $4.01B | +4 | — |
| Q3 2025 | 17 | 0 | 26.31M | $1.75B | +2 | −2 |
| Q2 2025 | 14 | -1 | 22.53M | $1.25B | +1 | −2 |
| Q1 2025 | 12 | +1 | 7.51M | $363.26M | +3 | −2 |
| Q4 2024 | 11 | -2 | 7.82M | $302.00M | — | −2 |
| Q3 2024 | 12 | +2 | 4.92M | $221.52M | +3 | −1 |
| Q2 2024 | 10 | — | 7.44M | $257.83M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasif) | 1.37M | +0.3% | $61.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasif) | 1.37M | +0.3% | $61.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.31M | +8.3% | $58.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.31M | +8.3% | $58.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Adage Capital Partners ✦ | 1.20M | -40.0% | $54.04M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | Marshall Wace ✦ | 315.37K | -44.9% | $14.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Point72 Asset Management ✦ | 214.87K | -76.4% | $9.67M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 158.07K | Baru | $7.11M | 0.0% | New | 1 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 144.17K | -51.5% | $6.49M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 137.17K | +447.5% | $6.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 137.17K | +447.5% | $6.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 137.17K | +447.5% | $6.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 30.08K | Baru | $1.35M | 0.0% | New | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 30.08K | Baru | $1.35M | 0.0% | New | 1 | SEC ↗ |
| 15 | Wellington Management ✦ | 30.08K | Baru | $1.35M | 0.0% | New | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 30.08K | Baru | $1.35M | 0.0% | New | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 26.82K | +104.0% | $1.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 5.71K | -93.1% | $256,995 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 5.03K | Baru | $226,350 | 0.0% | New | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Arrowstreet Capital | $7.11M | 0.0% |
| Wellington Management | $1.35M | 0.0% |
| Wellington Management | $1.35M | 0.0% |
| Wellington Management | $1.35M | 0.0% |
| Wellington Management | $1.35M | 0.0% |
| Citadel Advisors | $226,350 | 0.0% |
Telah keluar
| Millennium Management | $33.20M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 5.04K saham, $530,799 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer, Director · 34.24K lbr · $5.09M
Officer, Director · 65.76K lbr · $9.81M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi